In the context of cancer immunology, TGF-β was shown to downregulate NK-cell cytotoxic responses in addition to its ability to mediate the release of tumor supporting cytokines such as vascular endothelial growth factor (VEGF)-A (110, 111). Here, VEGFA is linked to neoplasm.